October 8, 2020
MOUNTAIN VIEW, Calif., Oct. 8, 2020 /PRNewswire/ — Lark Health today announced it has closed a $55 million Series C funding round led by King River Capital, as well as a $15 million venture debt credit facility with Trinity Capital and Bridge Bank. The round also includes new investors Franklin Templeton, SteelSky Ventures, and Olive Tree Capital; and existing Lark investors Lightspeed Ventures, Asset Management Ventures, Dr. Jonathan Fielding of UCLA Fielding School of Public Health, and Weili Dai, cofounder of Marvell. Lark has raised a total of over $100 million in equity and debt funding to date. FLG partner Bill Beyer assisted.
Full press release is here.